Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
Patrick Martin, Alisa Cohen, Sharif Uddin, Laura Epelbaum, Serene Josiah Shire, A Takeda Company, Lexington, MA, USACorrespondence: Patrick Martin Email ptmartin@alum.mit.eduPurpose: TAK-639 is a topical, nine-amino acid, synthetic, C-type natriuretic peptide analog in Phase 1 development for the tr...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-03-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/randomized-double-masked-placebo-controlled-dose-escalation-study-of-t-peer-reviewed-article-OPTH |